Ronald S. Freudenberger, MD, FACC

General Statement of Disclosure:

SPEAKER'S BUREAU: Amgen Inc.(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Medtronic(MODEST)

View Full Disclosure